← back to database
MVM Life Science Partners backs early-stage to late-stage life science companies to advance healthcare. It funds startups across biopharma, diagnostics, gene therapy, medical devices, vaccines, and life science tools. The firm operates globally with offices in Boston, London, and the San Francisco Bay Area, supporting portfolio companies worldwide. Investments total over $700 million across four funds, spanning start-up, mid venture, and late venture. The focus is on healthcare sectors and related services.
Investment focus
Investment style
Specialist
Data last enriched
Aug 14, 2026
Investing team
- Eric BednarskiManaging Partner
- Thomas CasdagliPartner
- Kevin ChengPartner
- Hugo HarrodPartner
- Jack TanakaPartner